Oberweis Asset Management Inc Champions Oncology, Inc. Transaction History

Oberweis Asset Management Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 14, 2020	SELL	$5.12 - $8.33 $278,184 - $452,593	-54,333 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$5.4 - $8.99 $34,020 - $56,637	6,300 Added 13.12%	54,333 $307,000
Q1 2019 May 15, 2019	BUY	$7.89 - $12.23 $85,212 - $132,084	10,800 Added 29.01%	48,033 $470,000
Q4 2018 Feb 14, 2019	BUY	$7.29 - $15.27 $271,428 - $568,547	37,233 New	37,233 $291,000

5.82M

15K

Ticker CSBR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 13,522,400
Market Cap $102M
Description
Champions Oncology, Inc. develops and sells technology solutions and products to personalize the development and use of oncology drugs in the United States. Its Tumorgraft Technology Platform is an approach to personalizing cancer care based upon the implantation of human tumors in immune-deficient mice. The company, through its Tumorgraft Techn...

Get notified when there are updates to the investment portfolio of Oberweis Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Oberweis Asset Management Inc with notifications on news.